Atai Beckley Aktie (A3CSB4

Was macht Atai Beckley?

Unternehmensprofil

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Chart der Atai Beckley Aktie

Charttool öffnen

Aktuelle Nachrichten zu Atai Beckley

Weitere Nachrichten

Das berichten andere über Atai Beckley

Washington beschleunigt die Psychedelika-Revolution. Drei Gewinner!

Die am 18. April 2026 unterzeichnete Executive Order zur Beschleunigung medizinischer Behandlungen für schwere psychische Erkrankungen markiert einen fundamentalen Wendepunkt...

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies

NEW YORK and AMSTERDAM, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company...

atai Life Sciences and Beckley Psytech complete strategic combination to form AtaiBeckley

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced that its previously annoucned strategic combination with Beckley Psytech has been completed, forming a...

atai Life Sciences closes $149.5M public offering, extending cash runway into 2029

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) announced the completion of a $149.5 million public offering of approximately 27 million common shares, including...